Financing
713-626-5544 -
3900 Essex Lane, Suite 101, Houston, TX 77027

Clinical Trials

 

CLINICAL TRIAL OPPORTUNITIES AT SLADE & BAKER VISION

Slade & Baker Vision is constantly being sought out by device and pharmaceutical companies to conduct clinical trials in order to help them gain FDA approval. Often, patients who are eligible for these clinical trials receive significant discounts for their participation. Current clinical trials being conducted at Slade & Baker Vision are listed below. 

If you are interested in participating in a current or future clinical trial listed below, please let us know by completing the entire contact form at the bottom of this page!

AMO Study

IRB ID: Version 1.0/23.Nov.16

DO YOU WANT TO REDUCE YOUR NEED FOR GLASSES FOR DISTANCE AND NEAR VISION?
If you are 40 years of age or older and have been diagnosed with cataracts in both eyes and have astigmatism, you may qualify for a research study conducted by Dr. Slade and Dr. Walton, our board-certified ophthalmologists. This study evaluates the clinical results of an FDA approved lens designed to provide both near and far vision and to correct astigmatism at time of cataract surgery. This lens may reduce your need for glasses.
Compensation is available for qualifying patients. Enrollment is limited.

If you are interested in participating, please contact:

Hospital/Site: Slade & Baker Vision

Contact Person Name:  Chadisty Pauly or Beverly Socop

Phone Number: 713-626-5544

 

RFO Study

IRB ID: 5811

Slade & Baker Vision is currently conducting a medical research study for people who have at least one eye that has impaired vision, who don't see well, or may not be able to see at all even with glasses or contacts.  The purpose of this study is to collect data on the basic safety and function of an investigational laser when used on people's eyes.  Participation would involve laser surgery on your eye with limited vision and at least 7 visits to our clinic.

You may qualify to participate in this research study IF:

  • You are at least 22 years of age or older
  • You have limited vision in at least one of your eyes
  • Your eye with limited vision:
    • Has not had previous surgery on the front of the eye (the cornea)
    • Has not had cataract surgery

If you are interested in participating, please contact:

Hospital/Site: Slade & Baker Vision

Contact Person Name:  Chadisty Pauly or Beverly Socop

Phone Number: 713-626-5544

 

PRK Study

We will be introducing some new PRK trials in the near future. If you are interested, please contact us by filling out the entire form at the bottom of this page and by calling 713-626-5544. 

 

If you are interested in participating in a current or future clinical trial listed above, please let us know by filling out the details in the contact form at the bottom of this page!

 

 

 

----- COMPLETED OR APPROVED TRIALS -----

Visumax SMILE 

Carl Zeiss Meditec and Slade & Baker Vision Center were conducting a research study on a new laser procedure, SMILE, designed to correct nearsightedness and astigmatism.

SMILE is an alternative to LASIK and designed to accomplish the same visual result as the LASIK procedure. It was finally FDA approved!
 
If you:
 
•  You have nearsightedness with astigmatism
•  You are at least 22 years of age
•  You have had no previous eye surgery, significant trauma or infections in either of your eyes.
•  You have a pair of glasses that are at least 1 year old
•  You are in good general health
•  You are willing to take your contact lenses out several weeks before surgery.
 
If you are all of the above and want to see if you are a candidate for SMILE, please call 713-626-5544.

 

Corneal Crosslinking (CXL) 

UPDATE:  As of April 2016, Corneal Crosslinking CXL is now APPROVED in the US by the FDA!  Slade & Baker Vision Center was the first site in Texas to perform corneal cross linking as part of a clinical trial. We are excited to announce that this trial has ended and CXL is now a regularly approved procedure in the US.  We offer screening evaluations, at no charge, for patients with corneal ectasia and/or KERATOCONUS to find out their options.

CXL is designed to treat Keratoconus, a disease that results in increasing nearsightedness and astigmatism. CXL may also be used to treat certain complications after refractive surgery (i.e. LASIK or PRK), primarily Post Lasik Ectasia patients that experience corneal thinning after Refractive Surgery. CXL treatment consists of a combination of applying Riboflavin drops, a B vitamin, to the front surface of the eye along with the use of an ultraviolet light. CXL has been approved in other parts of the world for multiple years and has now finally been approved in the US this year (2016). Dr. Slade was a lead investigator for the FDA Study that gained approval for this procedure. While any procedure, even wearing contact lenses, carries some risks, CXL is associated with low risks. In the other parts of the world, where CXL has been approved for years, results have been excellent.

The best first step is to come in to the clinic for a screening evaluation to find out if you are eligible. Please visit our corneal crosslinking page to learn more. We look forward to seeing you!

Please click on this link to view the press release on the approval of CXL.

 

Raindrop® Near Vision Corneal Inlay for PRESBYOPIA 

The Raindrop Clinical Study was being conducted at several specialized ophthalmology centers throughout the U.S. Slade & Baker Vision Center was the only site in Houston, TX where the clinical trial had been offered and as of August 30th 2016, Dr. Slade was the first surgeon in the US to perform the procedure outside of the clinical trials which was live streamed!  This was previously referred to as the "Presbylens" study.

Our research coordinator, Chadisty Pauly was recently honored by Revision Optics as the Research Coordinator of the year for the Raindrop study we participated in.

Fueled by a belief that no one should ever have to hold a menu out at arm’s length, RVO developed the Raindrop® Near Vision Corneal Inlay, a unique patented refractive surgery solution. This inlay is designed to improve the near vision that has been lost by the eye’s natural aging process, presbyopia. The Company is actively pursuing regulatory approvals for Raindrop® worldwide, and is committed to ridding the world of reading glasses, one satisfied patient at a time which is why Slade & Baker Vision Center has joined forces and offered this procedure to their patients.

Presbyopia is the loss of near vision with age and it typically happens to everyone over 40 years of age. The Raindrop procedure consists of the creation of a small LASIK-like flap made with a laser; the inlay is laid on the cornea under the flap; and the corneal flap is returned to its original position where it bonds without stitches. No corneal tissue is removed and the lens is removable if needed. This technique has been approved in Europe and we assisted in finally gaining its approval this month (July 2016) in the US! If you or a loved one has developed presbyopia, please visit our Raindrop Corneal Inlay page for more information on this procedure or call us at 713-626-5544 to set up an appointment.

 

T-CAT Study

This LASIK study was for patients who are nearsighted, farsighted or have astigmatism. In this study we used a new, custom LASIK treatment pattern. The treatment pattern had been approved in Europe and we were assisting in gaining its approval in the US. Early results were impressive. A significant reduction in the cost for LASIK was provided to patients for their participation. Qualifying patients were 18 years of age or older.

Clinical Trial

If you are interested in participating in one of our clinical trials, please let us know by completing the entire form below.

© Copyright 2016 Slade & Baker Vision Center, Houston Texas. All Rights Reserved.
Medical website design & SEO by Glacial Multimedia, Inc. & Patient Education Concepts, Inc.